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Introduction
Sudden sensorineural hearing loss (SSNHL) is a hearing loss of >30 dB in at least three consecutive frequencies that occurs in 3 days. 1 Five to 20 of every 100,000 people report this type of hearing loss, and it is usually one-sided. 2 SSNHL can be a possible consequence of many diseases, including autoimmune diseases, Ménière disease, tumors, vascular diseases, and viral inflammation. 3 The exact identification of the cause of SSNHL is usually possible, and the sudden deafness is classified as idiopathic. 4 Various studies of SSNHL have shown that patients' quality of life becomes impaired because of unilateral hearing loss and tinnitus. 5, 6 Patients also reported feelings of vertigo and ear fullness, which are likely to occur in SSNHL and can cause reduction in quality-of-life scores. 7, 8 The occurence of hearing loss in the opposite ear and the possibility of recurrence of hearing loss have been reported to cause anxiousness. 7 In addition, depressive symptoms can occur due to length of treatment and the social isolation that patients experience after the hearing loss. 6, 7 In this study, we aimed to assess levels of acute anxiety and depression reported by patients with one-sided hearing loss who were able to hear normally a short time earlier. We also attempted to determine whether a correlation exists between the severity of the disease and the consequent anxiety and depression.
Patients and methods
Ethical considerations. This study was conducted with the approval of the Institutional Ethical Committee (15.07.2015; 50687469-1491-409-15/1648.4-1292).
Inclusion and exclusion criteria. The study enrolled volunteer patients who were admitted to the Otolaryngology Department with complaints of sudden, one-sided hearing loss whose diagnosis was idiopathic SSNHL. Patients who previously had been diagnosed with or treated for anxiety or depression were not included. Also excluded were patients who were younger than 18 years; those experiencing hearing loss other than sudden, idiopathic, one-sided hearing loss; and those using psychiatric drugs or experiencing psychiatric disorders. Serving as controls were 45 individuals without symptoms of anxiety and depression from the same hospital. Baseline characteristics were similar between patients and controls.
Hearing evaluation. Hearing levels were assessed by pure-tone audiometry (PTA) to determine the mean hearing threshold for air conduction (AC) and bone conduction (BC) at frequencies of 500, 1,000, and 2,000 Hz. PTA was performed on the first, second, fifth, tenth, and twentieth days. Patients were classified according to the extent of their hearing loss: mild (26 to 40 dB), moderate (41 to 55 dB), moderate to severe (56 to 70 dB), severe (71 to 90 dB), and profound (≥91 dB).
9
Evaluation of anxiety and depression. Symptoms of anxiety and depression were evaluated in the department of psychiatry before treatment began. Symptoms of anxiety were evaluated with the Beck Anxiety Scale (BAS), which contains 21 symptom categories with four answer choices that are scored from 0 to 3.
To determine the risk for depression and the severity of depressive symptoms, the Beck Depression Inventory (BDI) was used, with questions pertaining to 21 symptom categories. To measure the negative expectations for patients in the future, the Beck Hopelessness Scale (BHS), consisting of 20 items scored 0 to 1, was used. These tests have all been validated in a Turkish population.
10,11
Statistical analysis. The Statistical Package for Social Sciences (SPSS, v. 15.0) pocket program was used to analyze the data obtained. Intragroup comparisons of continuous variables in dependent groups with no normal distribution were performed by the Wilcoxon test. The correlation between parameters was performed by Spearman correlation analysis at p < 0.05, which is considered statistically significant.
Results
A total of 56 patients (32 men [57.1%] and 24 women [42.9%]) with unilateral sudden hearing loss (SHL) who were 20 to 58 years old (mean: 32.8 ± 9.9 years) were recruited for the study. The mean age of the 45 controls was 33.1 ± 9.2 years. The mean air-conduction threshold of the PTA test was 61.1 ± 26.1 dB, and the mean bone-conduction threshold was 49.4 ± 13.8 dB.
Ten (17.9%) patients had a mild hearing loss, 23 (41.1%) had a moderate hearing loss, 8 (14.3%) had a moderate to severe hearing loss, 3 (5.4%) had a severe hearing loss, and 12 (21.4%) had a profound hearing loss. A total of 32 (57.1%) patients had hearing loss in the right ear and 24 (42.9%) experienced it in the left ear.
The mean score on the BAS was 19.5 ± 10.7 after the diagnosis of SHL. The mean score on the BAS in the control group was 4.1 ± 3.0, a difference that was statistically significant (p < 0.001).
Mild anxiety disorder was found in 23 (41.1%) patients, moderate anxiety disorder in 16 (28.6%), and severe anxiety disorder in 17 (30.4%).
The mean BDI score was 11.6 ± 8.4 in the patient group and 3.8 ± 2.1 in the control group (p < 0.001). Although scores of the test were normal in 25 (44.6%) patients, mild depressive disorder was found in 13 patients (23.2%) and moderate depressive disorder in 18 (32.1%).
The mean score on the BHS in the patients was 6.2 ± 4.7 at pretreatment stage compared a mean of 1.8 ± 1.0 in the control group (p < 0.001).
There was no significant correlation between the severity of hearing loss and scores on the BAS, BDI, or BHS ([r = 0.2, r = 0.6, and r = 0.1, respectively] [p = 0.1, p = 0.6, and p = 0.4, respectively]).
An evaluation of the effect of sex on anxiety and depressive disorders showed that women had mean scores of 24.4 ± 11.9, 11.9 ± 7.7, and 5.8 ± 4.6 on the BAS, BDI, and BHS, respectively, and the mean scores in men were 16.5 ± 8.6, 11.5 ± 9.0, and 6.5 ± 4.8, respectively. Although scores on the BAS and BDI in women were higher than those in men, no significant difference was found between scores of women and men on any of the scales (p = 0.3, p = 0.4, and p = 0.2, respectively).
Discussion
Different definitions of SSNHL have been presented, but the most widely accepted definition is a SNHL of >30 dB at three consecutive pure-tone frequencies occuring within 3 days.
12-14 SSNHL is an otologic emergency that should be diagnosed and treated as soon as possible. Although viral infections, autoimmune mechanisms, vascular flow disorders, membrane rupture, and metabolic disorders can be its (asserted) causes, a definitive etiology has not yet been recognized.
15-18 Most cases of SSNHL are deemed idiopathic; the cause can be established in only 10% of the cases.
The quality of life of patients with SHL is compromised. In addition to the impact of the hearing loss itself, the quality of life decreases because of a weakening sense of direction, difficulty in understanding due to unilateral hearing loss, vertigo, and, especially, tinnitus. [5] [6] [7] [8] Patients report that they experience social, psychological, and family problems. Patients with hearing loss also report avoiding crowded places and experiencing social inhibition depending on the extent of hearing loss and tinnitus symptoms.
6,7 Long-time social inhibition causes social isolation and depression. 18, 19 The risk of developing depression in patients with SSNHL is increased by 2.2 times compared with controls. 6 Besides hearing loss, tinnitus, and vertigo, the fear of deafness due to hearing loss or recurrence of hearing loss despite regular treatment can cause severe anxiety and depression. Some studies suggest that depression could be a cause of hearing loss.
20,21
Medium-to long-term (average 1 year) outcomes have been examined in most of the studies that have investigated the relationship between SSNHL and quality of life and levels of anxiety and depression. The patients evaluated in these studies benefited totally or partially from treatment. Patients who benefited partially had complaints such as tinnitus or vertigo. In our study, anxiety and depression levels were assessed immediately after the patients were diagnosed with hearing loss and before the results of any treatment were known. We expected that the anxiety and depression levels might be higher at the beginning of the process and that the patients might need psychiatric assistance. Psychiatric evaluation of patients with SSNHL might be helpful in uncovering subclinical psychologic symptoms.
The BAS, which contains 21 symptom categories with four answer choices and a possible score for each category ranging from 0 to 3, has a highest attainable score of 63. A higher total score indicates severe anxiety. Anxiety levels, according to the BAS, are classified as mild (0 to 17 points), moderate (18 to 24 points), or severe (≥25 points). 22 In our study, based on BAS scores, 23 patients (41.1%) were experiencing mild anxiety, 16 (28.6%) were experiencing moderate anxiety, and 17 (30.4%) were experiencing severe anxiety disorders. The mean score of BAS was 19.5 ± 10.7 in the patient group compared with 4.1 ± 3.0 in the control group, a difference that reached significance (p < 0.001).
Using the BDI, which has questions for 21 symptom categories and a highest possible score of 63, the severity of depression is classified as no depression (0 to 13 points) mild depression (14 to 19 points), moderate depression (20 to 28 points), and high depression (29 to 63 points). 23 In our study, although BDI test scores were normal in 25 (44.6%) patients, 13 patients (23.2%) were experiencing mild depression and 18 (32.1%) were experiencing moderate depression. The mean score of BDI was 11.6 ± 8.4 in the patient group compared with 3.8 ± 2.1 in the control group (p < 0.001).
The 20-item BHS evaluates the extent of hopelessness regarding the future. A respondent can score 0 or 1 on each item. In our country, Seber et al conducted validity and reliability processes in 1993. 24 The individual checks yes if it is appropriate to him/her or no if it is inappropriate. High scores show more hopelessness. In our study, the patient group's mean BHS score was 6.2 ± 4.7 in the pretreatment stage compared with a mean BHS score of 1.8 ± 1.0 in the control group, a difference that was statistically significant (p < 0.001).
Carlsson et al stated that a correlation exists between the severity of hearing loss and the quality of life in the later stages of SSNHL. 5 In our study, no correlation was found between the severity of hearing loss and symptoms of anxiety and depression (r = 0.22 and r = 0.6, respectively; p = 0.1 and p = 0.6, respectively). These results show that even slight hearing loss may cause significant psychiatric symptoms in the early stage.
Young patients are at much higher risk than older patients for psychiatric symptoms in SSNHL. 5 In contrast, no significant difference in risk has been found between sexes. 5 In our study, scores on scales of anxiety and depression were higher in women than in men, but the difference was not statistically significant.
Conclusion
Data obtained from the current study demonstrate that SSHNL may cause symptoms of anxiety and depression in the early stages of hearing loss. Patients may experience these symptoms despite only slight hearing loss, and these symptoms are generally more severe in women. In evaluating patients with SSNHL, clinicians should screen for subclinical psychologic symptoms and the need for psychiatric consultation.
In this study, we explored levels of acute anxiety and depression reported by patients with sudden one-sided hearing loss through the use of behavioral measures. Further studies are needed to validate the findings at the molecular level. One limitation of the current study is that patients might have had anxiety and depression in the past but had never reported it, perhaps because they were unaware of it.
We compared the mental state of a patient with a disease with that of a healthy person. Any disease in its acute form when it occurs in a healthy individual will lead to some levels of anxiety and depression. If a disease were to affect one of the sensory organs, it would cause even higher levels of depression. Comparing the levels of anxiety and depression of SSNHL patients with patients who have other acute diseases might be more suitable to determine levels of anxiety and depression of SSNHL patients.
